Bulletin de Périodique
Addiction , Vol.113, n°11 - November 2018
Paru le :
01/11/2018
Article en page(s) :
1965-2152
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Predatory monetization schemes in video games (e.g. 'loot boxes') and internet gaming disorder [Editorial]. King D.L., Delfabbro P.H., p. 1967-1969.
- AA attendance and abstinence for dually diagnosed patients: a meta-analytic review. Tonigan J.S., Pearson M.R., Magill M., Hagler K.J., p. 1970-1981.
- Commentary on Tonigan et al. (2018): Clarifying the evidence for the clinical and public health utility of Alcoholics Anonymous for dual-diagnosis patients. Kelly J.F., p. 1982-1983.
- Whole-of-community interventions to reduce population-level harms arising from alcohol and other drug use: a systematic review and meta-analysis. Stockings E., Bartlem K., Hall A., Hodder R., Gilligan C., Wiggers J., et al., p. 1984-2018.
- Is there gender convergence in risky drinking when taking birth cohorts into account? Evidence from an Australian national survey 2001-13. Livingston M., Callinan S., Dietze P., Stanesby O., Kuntsche E., p. 2019-2028.
- Commentary on Livingston et al. (2018): Change in gender ratios, what do they signify? Bratberg G.H., Haugland S.H., p. 2029-2030.
- Multi-level analysis of alcohol-related injury, societal drinking pattern and alcohol control policy: emergency department data from 28 countries. Cherpitel C.J., Witbrodt J., Korcha R.A., Ye Y., Kool B., Monteiro M., p. 2031-2040.
- The effect of parental drinking on alcohol use in young adults: the mediating role of parental monitoring and peer deviance. Mahedy L., MacArthur G.J., Hammerton G., Edwards A.C., Kendler K.S., Macleod J., et al., p. 2041-2050.
- Alcohol outlet density and alcohol related hospital admissions in England: a national small-area level ecological study. Maheswaran R., Green M.A., Strong M., Brindley P., Angus C., Holmes J., p. 2051-2059.
- Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014. Liang D., Bao Y., Wallace M., Grant I., Shi Y., p. 2060-2070.
- Commentary on Liang et al. (2018): The potential impact of medical cannabis on public health with respect to reducing prescription opioid use and associated harm. Rehm J., p. 2071-2072.
- Genome-wide association meta-analysis of age at first cannabis use. Minica C.C., Verweij K.J.H., van der Most P.J., Mbarek H., Bernard M., van Eijk K.R., et al., p. 2073-2086.
- Cigarette consumption and biomarkers of nicotine exposure during pregnancy and postpartum. Taghavi T., Arger C.A., Heil S.H., Higgins S.T., Tyndale R.F., p. 2087-2096.
- Commentary on Taghavi et al. (2018): Accurate measurement of tobacco smoke exposure and smoking behaviour matters. Coleman T., p. 2097-2098.
- Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e-cigarette and a tobacco cigarette. Farsalinos K.E., Yannovits N., Sarri T., Voudris V., Poulas K., Leischow S.J., p. 2099-2106.
- Independent predictors of mortality in adolescents ascertained for conduct disorder and substance use problems, their siblings and community controls. Border R., Corley R.P., Brown S.A., Hewitt J.K., Hopfer C.J., McWilliams S.K., et al., p. 2107-2115.
- Commentary on Border et al. (2018): The public health burden of conduct disorder, early mortality and criminal justice involvement. Aalsma M.C., p. 2116-2117.
- Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland. Fraser H., Mukandavire C., Martin N.K., Goldberg D., Palmateer N., Munro A., et al., p. 2118-2131.
- Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory. Rychert M., Wilkins C., p. 2132-2139.
- Addiction Lives: Ingeborg Rossow. Berridge V., p. 2140-2143.
- Harnessing the placebo effect: a promising method for curbing the opioid crisis? Bernstein M.H., Magill M., Beaudoin F.L., Becker S.J., Rich J.D., p. 2144-2145.
- Comment on the global gaming industry's statement on ICD-11 gaming disorder: a corporate strategy to disregard harm and deflect social responsibility? King D.L., p. 2145-2146.
- Predatory monetization schemes in video games (e.g. 'loot boxes') and internet gaming disorder [Editorial]. King D.L., Delfabbro P.H., p. 1967-1969.
- AA attendance and abstinence for dually diagnosed patients: a meta-analytic review. Tonigan J.S., Pearson M.R., Magill M., Hagler K.J., p. 1970-1981.
- Commentary on Tonigan et al. (2018): Clarifying the evidence for the clinical and public health utility of Alcoholics Anonymous for dual-diagnosis patients. Kelly J.F., p. 1982-1983.
- Whole-of-community interventions to reduce population-level harms arising from alcohol and other drug use: a systematic review and meta-analysis. Stockings E., Bartlem K., Hall A., Hodder R., Gilligan C., Wiggers J., et al., p. 1984-2018.
- Is there gender convergence in risky drinking when taking birth cohorts into account? Evidence from an Australian national survey 2001-13. Livingston M., Callinan S., Dietze P., Stanesby O., Kuntsche E., p. 2019-2028.
- Commentary on Livingston et al. (2018): Change in gender ratios, what do they signify? Bratberg G.H., Haugland S.H., p. 2029-2030.
- Multi-level analysis of alcohol-related injury, societal drinking pattern and alcohol control policy: emergency department data from 28 countries. Cherpitel C.J., Witbrodt J., Korcha R.A., Ye Y., Kool B., Monteiro M., p. 2031-2040.
- The effect of parental drinking on alcohol use in young adults: the mediating role of parental monitoring and peer deviance. Mahedy L., MacArthur G.J., Hammerton G., Edwards A.C., Kendler K.S., Macleod J., et al., p. 2041-2050.
- Alcohol outlet density and alcohol related hospital admissions in England: a national small-area level ecological study. Maheswaran R., Green M.A., Strong M., Brindley P., Angus C., Holmes J., p. 2051-2059.
- Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014. Liang D., Bao Y., Wallace M., Grant I., Shi Y., p. 2060-2070.
- Commentary on Liang et al. (2018): The potential impact of medical cannabis on public health with respect to reducing prescription opioid use and associated harm. Rehm J., p. 2071-2072.
- Genome-wide association meta-analysis of age at first cannabis use. Minica C.C., Verweij K.J.H., van der Most P.J., Mbarek H., Bernard M., van Eijk K.R., et al., p. 2073-2086.
- Cigarette consumption and biomarkers of nicotine exposure during pregnancy and postpartum. Taghavi T., Arger C.A., Heil S.H., Higgins S.T., Tyndale R.F., p. 2087-2096.
- Commentary on Taghavi et al. (2018): Accurate measurement of tobacco smoke exposure and smoking behaviour matters. Coleman T., p. 2097-2098.
- Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e-cigarette and a tobacco cigarette. Farsalinos K.E., Yannovits N., Sarri T., Voudris V., Poulas K., Leischow S.J., p. 2099-2106.
- Independent predictors of mortality in adolescents ascertained for conduct disorder and substance use problems, their siblings and community controls. Border R., Corley R.P., Brown S.A., Hewitt J.K., Hopfer C.J., McWilliams S.K., et al., p. 2107-2115.
- Commentary on Border et al. (2018): The public health burden of conduct disorder, early mortality and criminal justice involvement. Aalsma M.C., p. 2116-2117.
- Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland. Fraser H., Mukandavire C., Martin N.K., Goldberg D., Palmateer N., Munro A., et al., p. 2118-2131.
- Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory. Rychert M., Wilkins C., p. 2132-2139.
- Addiction Lives: Ingeborg Rossow. Berridge V., p. 2140-2143.
- Harnessing the placebo effect: a promising method for curbing the opioid crisis? Bernstein M.H., Magill M., Beaudoin F.L., Becker S.J., Rich J.D., p. 2144-2145.
- Comment on the global gaming industry's statement on ICD-11 gaming disorder: a corporate strategy to disregard harm and deflect social responsibility? King D.L., p. 2145-2146.
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
C. J. CHERPITEL ;
J. WITBRODT ;
R. A. KORCHA ;
Y. YE ;
B. KOOL ;
M. MONTEIRO
|
2018
Dans Addiction (Vol.113, n°11, November 2018) Article : Périodique
Dans Addiction (Vol.113, n°11, November 2018) Article : Périodique
BACKGROUND AND AIMS: Societal-level volume and pattern of drinking and alcohol control policy have received little attention in the alcohol and injury literature. The aim of this study was to estimate the association between alcohol-related inju[...]
M. LIVINGSTON ;
S. CALLINAN ;
P. DIETZE ;
O. STANESBY ;
E. KUNTSCHE
|
2018
Dans Addiction (Vol.113, n°11, November 2018) Article : Périodique
Dans Addiction (Vol.113, n°11, November 2018) Article : Périodique
BACKGROUND AND AIMS: Recent studies have argued that there has been substantial gender convergence in alcohol consumption. However, many of these rely on comparisons of different cohorts and do not adjust for age differences in male and female d[...]
E. STOCKINGS ;
K. BARTLEM ;
A. HALL ;
R. HODDER ;
C. GILLIGAN ;
J. WIGGERS ;
S. SHERKER ;
L. WOLFENDEN
|
2018
Dans Addiction (Vol.113, n°11, November 2018) Article : Périodique
Dans Addiction (Vol.113, n°11, November 2018) Article : Périodique
BACKGROUND AND AIMS: Whole-of-community interventions aim to reduce alcohol and other drug (AOD) use and harms by mobilizing community leaders, organizations and policy-makers to respond effectively to AOD use. The aim of this review is to estim[...]